REFERENCES
- Nangaku M. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17(1):17–25.
- Zoja C, Garcia PB, Remuzzi G. The role of chemokines in progressive renal disease. Front Biosci. 2009;14:1815–1822.
- Liu FY, Li Y, Peng YM, Relationship between clinical predictors and tubulointerstitial damage in adult-onset primary nephrotic syndrome. Arch Med Res. 2006;37(8): 981–986.
- Murphy M, Docherty NG, Griffin B, IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis. J Am Soc Nephrol. 2008;19(9):1672–1680.
- Diwakar R, Pearson AL, Colville-Nash P, The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells. Am J Physiol Renal Physiol. 2007;292(5):F1464–F1470.
- Grainger DJ, Heathcote K, Chiano M, Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93–97
- Babel N, Gabdrakhmanova L, Hammer MH, Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol. 2006;19(6):802–807.
- Khalil MS, El Nahas AM, Blakemore AI. Transforming growth factor-beta1 SNPs: Genetic and phenotypic correlations in progressive kidney insufficiency. Nephron Exp Nephrol. 2005;101(2):e31–e41.
- Yamada Y, Miyauchi A, Takagi Y, Association of the C-509T polymorphism, alone of in combination with the T869C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med. 2001;79:149–156.
- Gong WK, Cheung W, Yap HK. Minimal change nephrotic syndrome–a complex genetic disorder. Ann Acad Med Singap. 2000;29(3):351–356.
- Bakr AM, El-Chenawi F, Al-Husseni F. HLA alleles in frequently relapsing steroid-dependent and – resistant nephrotic syndrome in Egyptian children. Pediatr Nephrol. 2005;20(2): 159–162.
- Obeidová H, Merta M, Reiterová J, Genetic basis of nephrotic syndrome. Prague Med Rep. 2006;107(1):5–16.
- Hinkes BG, Mucha B, Vlangos CN, Nephrotic syndrome in the first year of life: Two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007;119(4):e907–e919.
- de Borst MH, Benigni A, Remuzzi G. Primer: Strategies for identifying genes involved in renal disease. Nat Clin Pract Nephrol. 2008;4(5):265–276.
- Liu FY, Li Y, Peng YM, Norcantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy. Am J Nephrol. 2008;28(3): 465–477.
- Hewitson TD. Renal tubulointerstitial fibrosis: Common but never simple. Am J Physiol Renal Physiol. 2009;296(6):F1239–F1244.
- Zhao J, Tramontano A, Makker SP. Albumin-stimulated TGFbeta-1 in renal tubular cells is associated with activation of MAP kinase. Int Urol Nephrol. 2007;39(4):1265–1271
- Lee SB, Kanasaki K, Kalluri R. Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int. 2009 Jul;76(1):10–12.
- Solari V, Owen D, Puri P. Association of transforming growth factor-beta1 gene polymorphism with reflux nephropathy. J Urol. 2005;174(4 Pt 2):1609–1611.
- Lim CS, Kim YS, Chae DW, Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol. 2005;63(2):61–67.
- Cho JH, Huh S, Kwon TG, Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients. Transplant Proc. 2008;40(7):2355–2360.
- Carturan S, Roccatello D, Menegatti E, Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. J Nephrol. 2004;17(6): 786–793.
- Sato F, Narita I, Goto S, Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens. 2004;64(1):35–42.